Pediatric Pharmacology update: COPD and Asthma Pediatric Guidelines
CE Information
1.0 contact hour (1.0 pharmacology)Completion Time
1 hourAvailable Until
December 31, 2024Posted By
Pacific Lutheran University
Navigate
Overview
Specialties
Acute Care, Allergy and Asthma, Emergency/Trauma, Family, Gastroenterology, Pediatrics, and School HealthClinical Topics
Asthma, COPD, Diabetes, New Drugs, Patient Outcomes, and RespiratoryDiscuss the role of leukotrienes
Review what is new in the GINA guideline
Discuss asthma exacerbation in the ED
Review changes to COPD management
Speakers
Inpatient pharmacist
I currently teach Advanced Pharmacotherapeutics in the DNP program lecturing in Nurs 731. I have presented for PLU’s continuing education seminars in topics of “Hypertension” and “Microdosing Psychedelics”. I work as an Inpatient pharmacist at Seattle Children’s Hospital. My career has been in adult hospitals for the past 20 years.
CE Information
This activity offers 1.0 contact hour (1.0 pharmacology) to attendees.
Accredited by Pacific Lutheran University Center for Continued Nursing Learning (PLU CCNL) is approved as a provider of nursing continuing professional development by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation..
Disclosures
None of the planners or presenters for this educational activity have relevant financial relationships to disclose with ineligible companies.
Activity Content
Registration to this activity includes access to the following supporting materials.
- 2024 Asthma and COPD Update.pdf (Size: 16.5 MB)
Duration: about 1 hour | Quality: HD
5 questions
Access your certificate
Register For This Activity
Pediatric Pharmacology update: COPD and Asthma Pediatric Guidelines